Société XSPY PHAR Nasdaq Stockholm
Actions
SE0009973563
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Per Andersson
CEO | Chief Executive Officer | 57 | 01/09/06 |
Director of Finance/CFO | 52 | 08/02 | |
Thomas Walz
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/22 |
Chief Tech/Sci/R&D Officer | 60 | 01/01/18 | |
Investor Relations Contact | 63 | 15/05/19 | |
Sales & Marketing | - | 15/03/22 | |
Andreas Konar
PRN | Corporate Officer/Principal | 75 | 01/01/10 |
Edward Jordan
PRN | Corporate Officer/Principal | 55 | 15/09/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 71 | 01/01/15 | |
Carl-Johan Spak
BRD | Director/Board Member | 68 | 01/01/15 |
Chairman | 70 | 19/05/22 | |
Director/Board Member | 55 | 01/01/17 | |
Christine Lind
BRD | Director/Board Member | 50 | 01/01/19 |
Director/Board Member | 66 | 01/01/21 | |
Robert Molander
BRD | Director/Board Member | 59 | 19/05/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 31 253 542 | 18 510 319 ( 59,23 %) | 0 | 59,23 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+18,72 % | 125 Md | |
+14,19 % | 108 Md | |
-4,93 % | 24,21 Md | |
+3,23 % | 22,78 Md | |
-10,44 % | 17,96 Md | |
-41,74 % | 16,43 Md | |
-13,31 % | 16,37 Md | |
+2,44 % | 13,58 Md | |
+27,89 % | 11,66 Md |